Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors.
European journal of medicinal chemistry • Vol. 180 • 2019
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
American journal of ophthalmology • Vol. 186 • 2018
Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics • Vol. 34, Issue 1-2 • 2018
Critical evaluation of latanoprostene bunod in the treatment of glaucoma.
Clinical ophthalmology (Auckland, N.Z.) • Vol. 10 • 2016
